Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.67
+0.63 (8.95%)
Aug 12, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Reiterates $10 → $11 | Buy | Reiterates | $10 → $11 | +43.42% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 10, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 5, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +121.64% | Jun 5, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $23 | Buy | Reiterates | $23 | +199.87% | Jun 3, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $25 | Buy | Maintains | $25 | +225.95% | May 5, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 1, 2026 |